DC-CIK联合化疗治疗晚期非小细胞肺癌的疗效分析  

Efficacy of DC-CIK combined with chemotherapy in the treatment of advanced non small cell lung cancer

作　　者：张士法[1] Zhang Shifa(Department of Thoracic Surgery,the First People's Hospital of Jining City 272000)

机构地区：[1]济宁市第一人民医院胸外科,272000

出　　处：《中国社区医师》2016年第29期44-45,共2页Chinese Community Doctors

摘　　要：目的:探讨DC-CIK联合化疗在晚期非小细胞肺癌中的治疗效果。方法:收治晚期非小细胞肺癌患者120例,分两组,对照组给予单纯化疗治疗,观察组给予DC-CIK联合化疗治疗,比较两组患者的治疗效果和不良反应的发生情况。结果:观察组的治疗有效率明显高于对照组,不良反应的发生率明显低于对照组(P<0.05)。结论:DC-CIK联合化疗在晚期非小细胞肺癌的治疗中,能够明显提高患者的治疗效果,增强抗肿瘤能力,减少不良反应的发生。Objective:To investigate the therapeutic effect of DC-CIK combined with chemotherapy in patients with advancednon-small cell lung cancer.Methods:120 patients with advanced non small cell lung cancer were selected.They were divided intotwo groups.The control group was treated with chemotherapy alone.The observation group was treated with DC-CIK combinedwith chemotherapy.The treatment effect and adverse reaction of the two groups were compared.Results:The effective rate of theobservation group was significantly higher than that of the control group,and the incidence of adverse reactions was significantlylower than that of the control group(P<0.05).Conclusion:DC-CIK combined with chemotherapy in the treatment of advancednon-small cell lung cancer can significantly improve the patient's treatment effect,enhance the ability to resist cancer,and reducethe incidence of adverse reactions.

关 键 词：DC-CIK 化疗 非小细胞癌 肺癌 

分 类 号：R734.2[医药卫生—肿瘤]